• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产时抗生素预防时代B族链球菌的耐药性问题

Issues of antimicrobial resistance in group B streptococcus in the era of intrapartum antibiotic prophylaxis.

作者信息

Edwards Morven S

机构信息

Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Semin Pediatr Infect Dis. 2006 Jul;17(3):149-52. doi: 10.1053/j.spid.2006.06.007.

DOI:10.1053/j.spid.2006.06.007
PMID:16934709
Abstract

The implementation of a culture screening-based approach to intrapartum antibiotic prophylaxis has been associated with substantial reduction in the incidence of early-onset group B streptococcal disease. Antibiotic prophylaxis is recognized as an interim strategy awaiting the licensure of a safe and effective conjugate vaccine for prevention of group B streptococcal infections in all susceptible populations. This article addresses concerns relating to antimicrobial resistance among group B streptococci that have arisen from use of intrapartum antibiotic prophylaxis and from increases in resistance in other gram-positive bacteria related genetically to group B streptococci.

摘要

采用基于培养物筛查的方法进行产时抗生素预防,已使早发型B族链球菌病的发病率大幅降低。抗生素预防被视为一种临时策略,等待一种安全有效的结合疫苗获得许可,用于预防所有易感人群中的B族链球菌感染。本文探讨了因产时抗生素预防的使用以及与B族链球菌在基因上相关的其他革兰氏阳性菌耐药性增加而引发的关于B族链球菌耐药性的问题。

相似文献

1
Issues of antimicrobial resistance in group B streptococcus in the era of intrapartum antibiotic prophylaxis.产时抗生素预防时代B族链球菌的耐药性问题
Semin Pediatr Infect Dis. 2006 Jul;17(3):149-52. doi: 10.1053/j.spid.2006.06.007.
2
[Prevention of early-onset group B streptococcus neonatal diseases. The 2005 experience of the Lille University Health Center].[早发型B族链球菌新生儿疾病的预防。里尔大学健康中心2005年的经验]
J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):392-9. doi: 10.1016/j.jgyn.2007.12.002. Epub 2008 Feb 20.
3
Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.产时化学预防时代的新生儿早发型B族链球菌病:遗留问题
J Perinatol. 2003 Jun;23(4):265-71. doi: 10.1038/sj.jp.7210899.
4
No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis.在产时抗生素预防时代,耐抗生素B族链球菌所致早发型新生儿败血症的发病率并未增加。
Am J Obstet Gynecol. 2005 Apr;192(4):1167-71. doi: 10.1016/j.ajog.2004.10.610.
5
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.产时抗生素预防时代的B族链球菌疾病
N Engl J Med. 2000 Jan 6;342(1):15-20. doi: 10.1056/NEJM200001063420103.
6
Antimicrobial susceptibility patterns of group B Streptococci isolated from pregnant women in Trinidad, West Indies.
Saudi Med J. 2004 Nov;25(11):1764-5.
7
Early-onset group B streptococcal disease in the era of maternal screening.孕产妇筛查时代的早发型B族链球菌病
Pediatrics. 2005 May;115(5):1240-6. doi: 10.1542/peds.2004-2275.
8
Group B streptococcal disease in infants: progress in prevention and continued challenges.婴儿 B 型链球菌病:预防进展和持续挑战。
Clin Perinatol. 2010 Jun;37(2):375-92. doi: 10.1016/j.clp.2010.02.002.
9
Intrapartum antibiotic prophylaxis and early-onset neonatal sepsis patterns.产时抗生素预防与早发型新生儿败血症模式
Infect Dis Obstet Gynecol. 2003;11(4):221-6. doi: 10.1080/10647440300025525.
10
Prevention of early onset group B streptococcal disease: controversial issues.早发型B族链球菌疾病的预防:争议问题
J Matern Fetal Neonatal Med. 2009;22 Suppl 3:38-42. doi: 10.1080/14767050903211521.

引用本文的文献

1
Phenotypic changes in group B streptococci grown in the presence of the polyols, erythritol, sorbitol and mannitol.B 群链球菌在多元醇,赤藓糖醇、山梨糖醇和甘露醇存在下生长时的表型变化。
BMC Microbiol. 2021 May 13;21(1):145. doi: 10.1186/s12866-021-02208-z.
2
Maternal exposures and the infant gut microbiome: a systematic review with meta-analysis.母体暴露与婴儿肠道微生物组:系统评价与荟萃分析。
Gut Microbes. 2021 Jan-Dec;13(1):1-30. doi: 10.1080/19490976.2021.1897210.
3
Implication of Soluble Forms of Cell Adhesion Molecules in Infectious Disease and Tumor: Insights from Transgenic Animal Models.
可溶性细胞黏附分子在感染性疾病和肿瘤中的意义:来自转基因动物模型的见解。
Int J Mol Sci. 2018 Jan 13;19(1):239. doi: 10.3390/ijms19010239.
4
Human milk oligosaccharides inhibit growth of group B .人乳寡糖可抑制B族(细菌)的生长。
J Biol Chem. 2017 Jul 7;292(27):11243-11249. doi: 10.1074/jbc.M117.789974. Epub 2017 Apr 17.
5
Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.拉美某医院侵袭性和非侵袭性无乳链球菌分离株的流行趋势:一项长达 17 年的研究。
BMC Infect Dis. 2014 Aug 3;14:428. doi: 10.1186/1471-2334-14-428.
6
The interplay between Siglecs and sialylated pathogens.唾液酸结合免疫球蛋白样凝集素(Siglecs)与唾液酸化病原体之间的相互作用。
Glycobiology. 2014 Sep;24(9):818-25. doi: 10.1093/glycob/cwu067. Epub 2014 Jul 4.
7
Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.B族链球菌通过模拟唾液酸与一种抑制性唾液酸结合免疫球蛋白样凝集素相互作用,从而减弱体内的先天免疫和炎症反应。
PLoS Pathog. 2014 Jan;10(1):e1003846. doi: 10.1371/journal.ppat.1003846. Epub 2014 Jan 2.
8
Penicillin susceptibility and macrolide-lincosamide-streptogramin B resistance in group B Streptococcus isolates from a Canadian hospital.加拿大某医院 B 群链球菌分离株的青霉素敏感性和大环内酯-林可酰胺-链阳性菌素 B 耐药性。
Can J Infect Dis Med Microbiol. 2012 Winter;23(4):196-8. doi: 10.1155/2012/540127.
9
Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment.母体抗体对 B 群链球菌 GAPDH 的抑制作用通过促进中性粒细胞募集而赋予后代免疫力。
PLoS Pathog. 2011 Nov;7(11):e1002363. doi: 10.1371/journal.ppat.1002363. Epub 2011 Nov 17.